학술논문
2011 - Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years.
Document Type
Article
Author
Source
Subject
*CONFIDENCE intervals
*HYPERCHOLESTEREMIA
*LONGITUDINAL method
*LOW density lipoproteins
*EVALUATION of medical care
*MORTALITY
*SURVIVAL analysis (Biometry)
*RANDOMIZED controlled trials
*RELATIVE medical risk
*BLIND experiment
*DESCRIPTIVE statistics
*SIMVASTATIN
*THERAPEUTICS
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1056-8751
Abstract
The article reports on a study according to which treatment with simvastatin reduced major vascular events at 5 years in at-risk patients. The study involved 536 patients who were 40 to 80 years of age most of them were men and at increased risk for vascular events. The primary results of the research resulted in coronary death of 34 percent of patients while others include vascular and non-vascular mortality and cancer.